@article{oai:repo.qst.go.jp:00047015,
 author = {藤林, 康久 and et.al and 藤林 康久},
 issue = {2},
 journal = {Hellenic Journal of Nuclear Medicine},
 month = {Oct},
 note = {Treatment of recurrent prostate cancer (PC) after radical prostatectomy is based on the site of recurrent disease [1-3].  In a previous study, we showed that carbon-11 acetate positron emission tomography (AC PET) demonstrated marked uptake in 27/46 of PC patients in recurrence after radical prostatectomy
(RP), while serum PSA was higher than 3.0ng/mL [4].  In the present paper we studied 11 patients with PC following RP, who had no clinical signs of recurrence, with PSA levels of>1.0 or 1.0-3.0ng/mL and under recent hormone treatment.},
 pages = {146--147},
 title = {Carbon-11-acetate positron emission tomography (PET), versus fluorine-18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of >1 to 3ng/mL.},
 volume = {16},
 year = {2013}
}